Inner Mongolia Puze Bioproducts Co., Ltd. was established in August 2008 and was initiated and founded by Inner Mongolia Institute of Light Industry and Sciences. The company is located in the west area of ​​Jinchuan Industrial Park, the Economic and Technological Development Zone of Hohhot City, covering an area of ​​22 mu and a total construction area of ​​more than 10,000 square meters. It was officially completed and put into production in July 2010. The company is a company specializing in the research, development and sales of probiotics and related products. The company's products include probiotic freeze-dried powder raw materials, dairy fermentation agents, probiotic foods, probiotic health foods and animal probiotic feed additives, etc. The designed scale is 200 tons of probiotic powder annually, and the output value can exceed one billion after reaching production. RMB.

The company has built a modern factory and pilot workshop that meets the GMP standard for human drugs, and has also built an internationally advanced multi-functional probiotic experimental center. At the same time, it has introduced production equipment with internationally advanced levels and precise experimental and testing instruments. The company strictly produces in accordance with GMP standards, has a strict quality control network and quality assurance system, and the production process reaches standardization, standardization and refinement, and the production process reaches fermentation program control, inspection automation, conveying pipelineization and packaging mechanization to ensure that the product reaches high level. Quality, high stability and high safety.

The company's founding shareholder, Inner Mongolia Light Industry Research Institute, was established in 1956. Since the 1970s, it has carried out research and development of lactic acid bacteria starters and a series of probiotic preparations, and has successively developed Bifidobacterium longum, Lactobacillus bulgaricus, and A series of products such as Streptococcus hotspots, Lactobacillus derella, Lactobacillus acidophilus and Bacillus subtilis. The national first-class new drug "Jin Shuangqi", which was successfully developed in 1997, is a three-linked probiotic live bacteria preparation with international advanced level. After Puze Biotechnology was completed, the business of the former Light Industry Research Institute has been fully incorporated into Puze Biotechnology, providing strong technical and talent guarantees for the subsequent development of Puze Biotechnology.

Based on the original drug - Triple Live Bacteria Tablets, the company's R&D team has developed a new generation of four-linked probiotic live bacteria preparation "Living Bacteria King Powder" through strain optimization, compatibility optimization, deep embedding, and activity improvement. "Fungi Doctor's Tablet". "Living Bacteria King" is specially developed for the elderly and the elderly, and has a good effect on improving intestinal problems in the elderly and preventing chronic diseases. "Fungi Doctor" applied to the State Food and Drug Administration for health food with the function of "adjusting intestinal microbial flora and laxative" to the State Food and Drug Administration in 2015. Expert review has been approved and is expected to obtain product approval documents in the second half of 2017. The company's probiotic product "Yidong" developed for pets has been sold in more than 1,000 pet hospitals across the country for three years, with terminal sales exceeding 20 million yuan; the series of probiotic feed additives developed for breeding large animals can Significantly reduce the use of antibiotics during breeding, bringing good news to people's dining table safety. The company plans to launch a human-use probiotic product in the near future: Lactobacillus casei live bacteria capsules that enhance immunity; Bifidobacteria organic selenium live bacteria tablets that assist in tumor treatment; Natto Hongqu Ginkgo Capsules that assist in lowering blood lipids, etc. These products have been developed for several years, have good clinical effects and huge market space, which will surely bring better economic benefits to Puze Bio.